BIOMERICA INC Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
BIOMERICA INC (BMRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 195.00 thousand shares for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-04-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-04-13
- BIOMERICA INC share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-02-28 was 185.00K shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-11-30 was 0.00 shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-08-31 was 10.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month |
|---|---|---|---|
| 2026-02-28 | 185.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-13 | 185.00K shares derived: sum of 2 quarters · filed 2026-04-13 | 195.00K shares 10-Q · filed 2026-04-13 |
| 2025-11-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-14 | 10.00K shares 10-Q · filed 2026-01-14 | |
| 2025-08-31 | 10.00K shares 10-Q · filed 2025-10-14 | ||
| 2025-02-28 | 780.00K shares 10-Q · filed 2025-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |